138 related articles for article (PubMed ID: 35584004)
21. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
[TBL] [Abstract][Full Text] [Related]
22. Craniopharyngiomas: A clinicopathological and molecular study of 52 cases - Experience in the Complejo Hospitalario de Toledo and Hospital Universitario 12 de Octubre (Madrid).
Moreno-Torres B; Campos-Martín Y; Meléndez B; Garcia Martin RM; Vicente A; Rodríguez de Lope Á; Alen JF; Mollejo M; Hernández-Laín A
Clin Neuropathol; 2021; 40(1):26-35. PubMed ID: 33040839
[TBL] [Abstract][Full Text] [Related]
23. Pathology and pathogenesis of craniopharyngiomas.
Larkin SJ; Ansorge O
Pituitary; 2013 Mar; 16(1):9-17. PubMed ID: 22886701
[TBL] [Abstract][Full Text] [Related]
24. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
Crago AM; Chmielecki J; Rosenberg M; O'Connor R; Byrne C; Wilder FG; Thorn K; Agius P; Kuk D; Socci ND; Qin LX; Meyerson M; Hameed M; Singer S
Genes Chromosomes Cancer; 2015 Oct; 54(10):606-15. PubMed ID: 26171757
[TBL] [Abstract][Full Text] [Related]
25. Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas.
Hölsken A; Kreutzer J; Hofmann BM; Hans V; Oppel F; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
Brain Pathol; 2009 Jul; 19(3):357-64. PubMed ID: 18540944
[TBL] [Abstract][Full Text] [Related]
26. Genomic drivers in craniopharyngiomas: Analysis of the AACR project GENIE database.
Lehrich MB; Tong CLC; Hsu PKF; Kuan CE
Childs Nerv Syst; 2024 Jun; 40(6):1661-1669. PubMed ID: 38421446
[TBL] [Abstract][Full Text] [Related]
27. Targeted therapies in the medical management of craniopharyngioma.
Iglesias P
Pituitary; 2022 Jun; 25(3):383-392. PubMed ID: 35301645
[TBL] [Abstract][Full Text] [Related]
28. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
[TBL] [Abstract][Full Text] [Related]
29. Multi-omics analysis of adamantinomatous craniopharyngiomas reveals distinct molecular subgroups with prognostic and treatment response significance.
Wang X; Zhao C; Lin J; Liu H; Zeng Q; Chen H; Wang Y; Xu D; Chen W; Xu M; Zhang E; Lin D; Lin Z
Chin Med J (Engl); 2024 Apr; 137(7):859-870. PubMed ID: 37565822
[TBL] [Abstract][Full Text] [Related]
30. Molecular biological features of cyst wall of adamantinomatous craniopharyngioma.
Zhao C; Wang Y; Liu H; Qi X; Zhou Z; Wang X; Lin Z
Sci Rep; 2023 Feb; 13(1):3049. PubMed ID: 36810626
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma.
Andoniadou CL; Gaston-Massuet C; Reddy R; Schneider RP; Blasco MA; Le Tissier P; Jacques TS; Pevny LH; Dattani MT; Martinez-Barbera JP
Acta Neuropathol; 2012 Aug; 124(2):259-71. PubMed ID: 22349813
[TBL] [Abstract][Full Text] [Related]
32. Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models.
Martinez-Barbera JP; Buslei R
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):7-17. PubMed ID: 25503464
[TBL] [Abstract][Full Text] [Related]
33. Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma.
Martinez-Barbera JP
Neuropathol Appl Neurobiol; 2015 Oct; 41(6):721-32. PubMed ID: 25611703
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
[TBL] [Abstract][Full Text] [Related]
35. 60 YEARS OF NEUROENDOCRINOLOGY: Biology of human craniopharyngioma: lessons from mouse models.
Martinez-Barbera JP
J Endocrinol; 2015 Aug; 226(2):T161-72. PubMed ID: 25926515
[TBL] [Abstract][Full Text] [Related]
36. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
[TBL] [Abstract][Full Text] [Related]
37. Biological Behaviour of Craniopharyngiomas.
Martinez-Barbera JP; Andoniadou CL
Neuroendocrinology; 2020; 110(9-10):797-804. PubMed ID: 32126562
[TBL] [Abstract][Full Text] [Related]
38. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic control of adamantinomatous craniopharyngiomas.
Marrero-Gutiérrez J; Bueno AC; Martins CS; Coeli-Lacchini FB; Silva-Júnior RMP; Marques Gonçalves GH; Ozaki JGO; de Almeida E Silva DC; Wildemberg LE; da Silva Antunes XL; Dos Santos AC; Machado HR; Santos MV; Moreira AC; Gadelha MR; Vêncio RZN; Antonini SRR; de Castro M
J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38181427
[TBL] [Abstract][Full Text] [Related]
40. Identification of CTNNB1 mutations, CTNNB1 amplifications, and an Axin2 splice variant in juvenile angiofibromas.
Wemmert S; Willnecker V; Kulas P; Weber S; Lerner C; Berndt S; Wendler O; Schick B
Tumour Biol; 2016 Apr; 37(4):5539-49. PubMed ID: 26572152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
